title: International intellectual property strategies for therapeutic antibodies.
abstract: Therapeutic antibodies need international patent protection as their markets expand to include industrialized and emerging countries. Because international intellectual property strategies are frequently complex and costly, applicants require sound information as a basis for decisions regarding the countries in which to pursue patents. While the most important factor is the size of a given market, other factors should also be considered.
authors: Michalski Huettermann Patent Attorneys, Duesseldorf, Germany. st@mhpatent.de
authors: Ulrich
authors: U
authors: Storz
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D001709:Biotechnology / Q000331:legislation & jurisprudence; D003132:Commerce / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence; D006801:Humans; D018973:Intellectual Property; D007391:International Cooperation; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
chemical_list: D000906:Antibodies